Cargando…
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome
Epithelial ovarian cancer (EOC) is divided into type I and type II based on histopathological features. Type I is clinically more indolent, but also less sensitive to chemotherapy, compared with type II. The basis for this difference is not fully clarified. The present study investigated the pattern...
Autores principales: | Bjersand, Kathrine, Blom, Kristin, Poromaa, Inger Sundström, Stålberg, Karin, Lejon, Ann-Marie, Bäckman, Fatma, Nyberg, Åsa, Andersson, Claes, Larsson, Rolf, Nygren, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477110/ https://www.ncbi.nlm.nih.gov/pubmed/36082820 http://dx.doi.org/10.3892/ijo.2022.5418 |
Ejemplares similares
-
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015) -
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer
por: Bjersand, Kathrine, et al.
Publicado: (2017) -
Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
por: Cashin, Peter H, et al.
Publicado: (2023) -
Advanced gynecological cancer: Quality of life one year after diagnosis
por: Jónsdóttir, Björg, et al.
Publicado: (2023) -
The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer
por: Jónsdóttir, Björg, et al.
Publicado: (2020)